REG - Warpaint London PLC - Change of Advisers

Warpaint LondonAnnouncement

16/07/2020 07:00

RNS Number : 1258T
  
Warpaint London PLC
  
16 July 2020
  
 

16 July 2020
 
Warpaint London PLC
("Warpaint", the "Company" or the "Group")
Change of Advisers
 
Warpaint London plc, the specialist supplier of colour cosmetics and owner of the W7 and Technic brands, is pleased to announce that it has appointed N+1 Singer as Nominated Adviser and Joint Broker and Shore Capital as Joint Broker, both with immediate effect. 
 
Enquiries:




Warpaint London
Sam Bazini - Chief Executive Officer
Eoin Macleod - Managing Director
Neil Rodol - Chief Financial Officer
 


c/o IFC
 




N+1 Singer (Nominated Adviser & Joint Broker)
Shaun Dobson, Alex Bond - Corporate Finance

Tom Salvesen - Corporate Broking


020 7496 3000
 




Shore Capital (Joint Broker)
Patrick Castle 
Daniel Bush 
 


020 7408 4090




IFC Advisory (Financial PR & IR)
Tim Metcalfe
Graham Herring
Florence Chandler


020 3934 6630
 




 
 
Notes to editors:
Warpaint London plc
Warpaint London plc is made up of two divisions.
The largest division sells cosmetics under the lead brand names of W7, Technic and Body Collection. W7 is sold in the UK primarily to retailers and internationally to local distributors or retail chains. The Technic brand is sold in the UK and continental Europe with a significant focus on the gifting market, principally for high street retailers and supermarkets. In addition, this division supplies own brand white label cosmetics produced for several major high street retailers. The Group also sells cosmetics using our other brand names of Man'stuff, Vintage, Very Vegan and Chit Chat.
The other division trades in close-out and inventory of branded cosmetics and fragrances from around the world.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
APPMZGMNKKRGGZM